Ironwood Pharmaceuticals, Inc. (IRWD) Stock Grade

About Ironwood Pharmaceuticals, Inc.'s fundamentals

Ironwood Pharmaceuticals is a specialty pharmaceutical company with a market capitalization of $678.2 million that is currently unprofitable on an equity basis, as indicated by the unavailable return on equity figure. The company experienced a significant revenue decline of 15.7% year-over-year, though it maintains a positive net margin of 8.1%, suggesting profitability on existing sales. Trading at a P/E ratio of 22.8, the valuation reflects expectations that may be looking beyond the current revenue contraction. The company does not pay a dividend, indicating cash is being retained for operations or potential reinvestment.